Endograft use in the femoral and popliteal arteries.
The results of infra-inguinal intervention for atherosclerotic occlusive disease have not changed dramatically in the last 15 years despite the advent of many different designs of uncovered stents. "Plain old balloon angioplasty" remains the treatment of choice for short lesions (<3 cm) with good morphologic characteristics. Stents have improved suboptimal angioplasty results somewhat, but results in longer lesions >5 cm have remained poor in most series. Although there are no endografts currently approved for arterial use by the FDA, expanded polytetraflouroethylene (ePTFE) covered endoprostheses are available and their use in the femoropopliteal arteries can dramatically improve the results of endovascular treatment for longer lesions and allow one to treat vascular ruptures and aneurysms. In this article, we will review the published results for the use of endografts in the femoropopliteal arteries and describe what we believe to be the current indications for their use.
Saxon
Richard R
RR
San Diego Vascular Institute, Diagnostic Imaging and Interventional Radiology, Tri-City Medical Center, Oceanside, CA, USA.
Coffman
Jeanine M
JM
Gooding
Justin M
JM
Ponec
Donald J
DJ
D000497:Alloys; D000783:Aneurysm / Q000628:therapy; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000628:therapy; D004617:Embolism / Q000209:etiology; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000000981:diagnostic imaging; D011859:Radiography; D015607:Stents / Q000009:adverse effects; D014654:Vascular Patency
D000497:Alloys; C013616:nitinol; D011138:Polytetrafluoroethylene